IP Library › Granted Patent US 10,463,595
Granted Patent B2
US 10,463,595 · App. 15/864,264 · Granted Nov 5, 2019

Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof

Inventors: Geoffrey C. Gurtner (Stanford, CA); Kenneth N. Horne (San Francisco, CA); Jayakumar Rajadas (Cupertino, CA)
Assignee: ALLERGAN HOLDINGS FRANCE S.A.S.
A61K8/735A61K8/027A61K8/0216A61K8/42A61K8/65A61K31/728A61L15/28A61L17/005A61L17/04A61L17/06A61L17/10A61L27/20A61L27/54A61L31/042A61Q19/08B29C48/05C08B37/0072C08L5/08A61K2800/805A61L2300/236A61L2300/402A61L2430/34C08L2205/025Y10T428/2929
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,463,595
App. No.
15/864,264
Granted
Nov 5, 2019
Kind
B2
Abstract

The present invention provides threads of hyaluronic acid, and/or derivatives thereof, methods of making thereof and uses thereof, for example, in aesthetic applications (e.g., dermal fillers), surgery (sutures), drug delivery, etc.

Claims (19)

1. A method of making an implantable device for treating wrinkles in skin, the method comprising:

mixing hyaluronic acid or salts, hydrates or solvates thereof with water or an aqueous buffer;

causing at least some of the hyaluronic acid or salts, hydrates or solvates thereof to become crosslinked with a crosslinker, to form a gel containing crosslinked and non-crosslinked hyaluronic acid;

extruding the gel into a thread; and

drying the extruded thread to form a dried thread useful for treating wrinkles in skin.

2. The method of claim 1 , further comprising mixing a therapeutic agent with the hyaluronic acid.

3. The method of claim 2 , wherein the therapeutic agent is lidocaine.

4. The method of claim 1 , further comprising hydrating the dried thread.

5. The method of claim 1 , wherein the crosslinker is selected from the group consisting of butanediol diglycidyl ether (BDDE), divinyl sulfone (DVS) and 1-ethyl-3-(3-dimethylam inopropyl) carbodiimide hydrochloride (EDC).

6. The method of claim 1 , wherein the crosslinker is butanediol diglycidyl ether (BDDE).

7. The method of claim 1 , wherein the dried thread has an in vivo lifetime between about 1 week and about 24 months.

8. The method of claim 7 , wherein the in vivo lifetime is between about 3 months and about 9 months.

9. The method of claim 2 , wherein the therapeutic agent is botulism toxin.

10. The method of claim 1 , wherein the dried thread has a tensile strength of between about 1 kpsi and about 125 kpsi.

11. The method of claim 1 , wherein the dried thread has an axial tensile strength of between about 0.01 pounds and about 10 pounds.

12. The method of claim 1 , wherein the dried thread has a cross-section area of between about 1×10 6 in 2 and about 1,000×10 6 in 2 .

13. The method of claim 1 , wherein the dried thread has a diameter of between about 0.0001 inches and about 0.100 inches.

14. The method of claim 1 , wherein the dried thread has an elasticity of between about 1% and about 200%.

15. The method of claim 1 , wherein the dried thread has a cross-sectional area that when fully hydrated swells to between about 0% to about 10,000%.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2019
From: GURTNER, GEOFFREY C.; HORNE, KENNETH N.; RAJADAS, JAYAKUMAR
To: TAUTONA GROUP LP
Reel/Frame 049979/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2018
From: TAUTONA GROUP, LP
To: ALINE AESTHETICS, LLC.
Reel/Frame 044577/0265 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2018
From: ALINE AESTHETICS, LLC.
To: ALLERGAN HOLDINGS FRANCE S.A.S.
Reel/Frame 044577/0328 →
Continuity (4)
Division 14947409 · Nov 20, 2015
Continuation 13060919
Provisional Application 61190866 · Sep 2, 2008
Related Publication 20180344610A1 · Dec 6, 2018